The launch issue of this column spent most of its length on global frameworks — the WHO global oral health strategy, the disease burden figures, the structural framing from 2008 that has not been substantially revised since. This issue is closer to home. Four source-market items, one destination-market item, and a closing paragraph on the tension this column will not paper over. Concede-pivot on each, in the same register as last week.
The source-market items are not new research. They are the public record — government data, program documentation, epidemiological surveys — on the domestic cost and coverage conditions that produce dental tourism demand. They predate dental tourism as a phenomenon. They will outlast it. The column’s job is to read them without flinching at what they say.
1. Australia: AIHW data on dental cost avoidance
The Australian Institute of Health and Welfare publishes a national oral health dataset. The AIHW oral health and dental care report https://www.aihw.gov.au/reports/dental-oral-health/oral-health-and-dental-care-in-australia documents a figure that has appeared in successive editions: approximately one in three Australian adults avoids or delays dental care due to cost. The AIHW dental overview https://www.aihw.gov.au/reports-data/health-conditions-disability-deaths/dental-oral-health/overview contextualises this against coverage: Medicare, Australia’s universal public insurance scheme, excludes most dental care for adults. Private health insurance extras-tier coverage exists but carries annual benefit caps that are typically exhausted on a single major procedure. The structural consequence is that a large share of the adult population sits outside meaningful dental coverage and moderates consumption through avoidance.
Concede. An avoidance rate of one in three adults is a system-level signal. It is not an anomaly produced by individual financial irresponsibility. A country with a universal public hospital system and a mature private health sector has, for reasons that long precede current government, left most adult dental care outside the universal floor. The Wikipedia entry on healthcare in Australia https://en.wikipedia.org/wiki/Healthcare_in_Australia notes that the 1984 Medicare legislation that established the current system did not include dental. That exclusion is now four decades old. It has survived changes of government in both directions.
Pivot. Cost avoidance is not a neutral term. A patient who avoids dental care for two years because they cannot afford it does not present, when they finally do seek care, with the same case they would have presented with two years earlier. Deferred maintenance becomes deferred pathology. The AIHW data on avoidance is also, implicitly, data on the case complexity that accumulates in the avoidance cohort. For the detailed four-country argument on how this accumulation produces the specific patient profile that is simultaneously the most motivated to travel internationally and the least well-suited to the high-volume cosmetic clinic model, see the dental care access crisis long read and the Australia-specific cost data reference page.
2. New Zealand: the frozen adult dental benefit
New Zealand’s public dental benefit for adults has been described, in successive Budget rounds, as effectively frozen. The Wikipedia entry on healthcare in New Zealand https://en.wikipedia.org/wiki/Healthcare_in_New_Zealand records that New Zealand’s publicly funded dental care is largely limited to children and adolescents under the Community Oral Health Service, with adult coverage subject to means testing and low benefit ceilings. The benefit level available to eligible adults has not tracked dental fee inflation. The arithmetic is therefore similar to Australia’s: full private fee, partial subsidy available only to a subset of lower-income adults, no universal adult dental floor.
Concede. New Zealand operates under tighter fiscal constraints than Australia by absolute magnitude, and the political economy of extending adult dental coverage is not simpler there than it is anywhere else. The argument for adult dental inclusion in the public benefit has been made, repeatedly, by the New Zealand Dental Association and by public health academics, and has not prevailed in successive Budget processes. That is a fact about political priorities, not a moral failing of any individual minister.
Pivot. The policy gap is real regardless of how it came to exist. New Zealand adults seeking major restorative work — full-arch implant cases, crown-and-bridge work, complex endodontics — face the same full-market pricing that Australian adults face, against the same background of deferred maintenance that cost avoidance produces. The destination-country price differential for New Zealand patients travelling to Vietnam, Thailand, or Malaysia is, on some procedures, material. The New Zealand cost data reference page documents current domestic pricing against published destination-country ranges. The differential does not make the decision to travel internationally correct; it explains why the calculation gets made.
3. United States: Medicaid dental coverage as an optional benefit
Medicaid — the joint federal-state health coverage program for low-income Americans — treats dental coverage for adults as an optional benefit at the state level. The Wikipedia article on Medicaid https://en.wikipedia.org/wiki/Medicaid documents that states may elect to provide no adult dental coverage, emergency-only coverage, or comprehensive coverage. The distribution across states is uneven; a patient in one state may have access to restorative Medicaid dental benefits that a patient in an adjacent state does not. Medicare, the federal program for adults 65 and older, has historically excluded most dental coverage entirely, though limited expansions have been proposed in successive legislative cycles without passing into law.
Concede. The US dental coverage gap is not a new finding. The CDC figures on uninsured adults — which ran to approximately 68 million at the last major estimate — represent the structural floor beneath which no federal program currently operates. The employer-sponsored dental plan market covers a significant share of the working-age population, but annual maximum benefit caps, which have remained largely static in real terms for decades, mean that a single major restorative course of treatment can exhaust a year’s benefit and leave a significant patient contribution outstanding regardless.
Pivot. The US patient considering international dental care is not a marginal case. They represent a large, structurally uncovered or under-covered population making a rational calculation in the context of a coverage architecture that produces large out-of-pocket exposures for major dental work. The Wikipedia entry on dental tourism https://en.wikipedia.org/wiki/Dental_tourism identifies the United States as one of the primary source markets for outbound dental patients, and identifies cost as the dominant driver. That finding has been consistent across every major survey of the phenomenon. It is consistent with what Medicaid’s optional-dental structure and Medicare’s dental exclusion would predict.
4. Canada: the Canadian Dental Care Plan and rollout friction
The Canadian Dental Care Plan (CDCP), launched in phased rollout from late 2023, represents the most significant federal dental policy intervention in the primary English-speaking source markets in a generation. The Wikipedia article on the Canadian Dental Care Plan https://en.wikipedia.org/wiki/Canadian_Dental_Care_Plan documents the program’s structure: means-tested, targeted initially at children, seniors, and people with disabilities, with full rollout to working-age uninsured adults completing progressively through 2025.
Concede. The CDCP is a genuine policy development. It is the product of sustained political effort and represents real incremental coverage for populations that had none. The program’s political history — including its origins in a confidence-and-supply agreement — does not diminish its significance as a coverage instrument for the populations it reaches.
Pivot. The CDCP does not cover the middle-income working-age adult who holds a modest private dental plan with a low annual maximum and faces a major restorative quote that exceeds it. The program’s means-testing structure means that a patient earning above the income thresholds, with a private plan that covers two check-ups and a cleaning annually, receives no federal benefit on a $15,000 full-arch implant case. That population — private-plan-holding, above the CDCP threshold, facing a major restorative episode — is a significant slice of the demand that destination-country implant clinics target with Canadian-market advertising. The CDCP rollout is a meaningful development. It is not a structural resolution of the cost pressures that produce outbound dental tourism from Canada.
5. Thailand’s health system and the dual-market structure
The WHO’s Thailand health-system profile https://www.who.int/thailand/health-topics/health-system documents a system that achieved universal health coverage through the Universal Coverage Scheme (UCS) in 2002, covering approximately 75% of the population through that scheme alone alongside civil servant and social security schemes. Thailand’s public dental services operate within the UCS framework.
Concede. Thailand’s achievement of near-universal health coverage — and the political durability of that coverage through successive governments and a military period — is a genuine public health accomplishment. The WHO profile locates Thailand among the countries that have advanced universal coverage most substantially in the Southeast Asian region. Bangkok’s role as a regional medical hub has developed alongside, not instead of, its public health infrastructure.
Pivot. Thailand’s public health system and Thailand’s private medical tourism market are not the same thing. A patient travelling from Sydney or Auckland or Calgary to a Bangkok private dental clinic is not accessing the Universal Coverage Scheme. They are accessing a private market that is, in Bangkok’s international corridor, priced and positioned for foreign patients and is subject to a regulatory oversight structure that is not the same as the public UCS framework. The WHO profile on the health system is evidence about the Thai public sector. It is not a validation of any private Bangkok clinic’s clinical standards, laboratory relationships, or complication management protocols. For what a patient can actually verify about a named private operator in a destination city, the column’s methodology is documented at the clinical standards framework. For the cross-country cost comparison including Thailand-market pricing, see the reference page.
The tension this column will not resolve
Readers of this column will have noticed a pattern in the four domestic items above. Australia, New Zealand, the United States, and Canada each have the same structural feature: a gap between what major restorative dental care costs and what any available public or private coverage instrument actually pays. The gap is not identical across countries or income levels, but in each case it is real, it is large relative to household dental budgets for a significant share of the population, and it is structural — produced by legislative decisions that are now measured in decades, not in policy cycles.
These structural failures predate dental tourism as a market phenomenon. They will outlast it. The price differential between a full-arch implant case in Melbourne or Auckland or Chicago and the same procedure in Bangkok or Ho Chi Minh City or Hanoi did not create the coverage failures. The coverage failures created the conditions under which a price differential of that magnitude is experienced as a genuine option rather than a theoretical curiosity. Dental tourism is a symptom, not a cause.
The tension this column will not pretend to resolve is this. The patient most strongly motivated to travel internationally for major dental care — the patient for whom the domestic price is genuinely unaffordable, for whom avoidance has been running for years, for whom the international quote represents the only realistic path to treatment — is also, on average, the patient with the most deferred, complex, and highest-risk case. The AIHW cost-avoidance data is not just data about financial behaviour. It is data about the clinical profiles that accumulate when financial barriers suppress dental utilisation over extended periods. A patient who has been avoiding a second opinion on mobile teeth, or on a failing bridge, or on recurrent pain, for three years because they could not absorb the domestic out-of-pocket cost is not a straightforward implant case. They are, in many instances, exactly the case that the high-volume cosmetic dental tourism clinic is structurally least well-configured to manage.
The next issue addresses this patient profile directly. For the detailed clinical argument on why the cost-deferred patient is the highest-risk international treatment profile — and for what a competent independent specialist review process looks like before any cross-border treatment decision — see This Week in Dental Tourism #3. For the longer structural argument on source-market coverage failure and the demand pool it generates, see the dental care access crisis long read. For what the trust problem in dental tourism looks like from the inside, see the dental tourism trust gap.